Ray Dalio Haemonetics Corp Transaction History

Bridgewater Associates, LP

$20.7 Billion
Q1 2025

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Haemonetics Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 21,520 shares of HAE stock, worth $1.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

21,520

Previous 5,392 299.11%

Holding current value

$1.49 Million

Previous $421,000 224.7%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$59.34 - $80.05 $957,035 - $1.29 Million	16,128 Added 299.11%	21,520 $1.37 Million
Q4 2024 Feb 13, 2025	SELL	$71.16 - $93.38 $173,203 - $227,286	-2,434 Reduced 31.1%	5,392 $421,000
Q3 2024 Nov 13, 2024	SELL	$72.45 - $91.58 $2.59 Million - $3.27 Million	-35,747 Reduced 82.04%	7,826 $628,000
Q2 2024 Aug 14, 2024	SELL	$81.24 - $97.37 $260,455 - $312,168	-3,206 Reduced 6.85%	43,573 $3.6 Million
Q1 2024 May 14, 2024	SELL	$71.24 - $85.35 $567,070 - $679,386	-7,960 Reduced 14.54%	46,779 $3.99 Million
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $436,233 - $501,297	-5,413 Reduced 9.0%	54,739 $4.68 Million
Q3 2023 Nov 13, 2023	BUY	$82.56 - $93.49 $409,249 - $463,429	4,957 Added 8.98%	60,152 $5.39 Million
Q2 2023 Aug 11, 2023	SELL	$80.84 - $89.45 $520,124 - $575,521	-6,434 Reduced 10.44%	55,195 $4.7 Million
Q1 2023 May 12, 2023	BUY	$72.75 - $90.6 $152,920 - $190,441	2,102 Added 3.53%	61,629 $5.1 Million
Q4 2022 Feb 13, 2023	SELL	$73.85 - $86.14 $1.58 Million - $1.85 Million	-21,454 Reduced 26.49%	59,527 $4.68 Million
Q3 2022 Nov 10, 2022	SELL	$63.3 - $78.66 $4,051 - $5,034	-64 Reduced 0.08%	80,981 $6 Million
Q2 2022 Aug 11, 2022	BUY	$49.27 - $66.08 $372,087 - $499,036	7,552 Added 10.28%	81,045 $5.28 Million
Q1 2022 May 13, 2022	BUY	$43.77 - $63.22 $766,762 - $1.11 Million	17,518 Added 31.3%	73,493 $4.65 Million
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $411,562 - $619,544	8,306 Added 17.42%	55,975 $2.97 Million
Q3 2021 Nov 12, 2021	SELL	$57.6 - $70.59 $243,993 - $299,019	-4,236 Reduced 8.16%	47,669 $3.37 Million
Q2 2021 Aug 13, 2021	BUY	$51.81 - $118.56 $2.69 Million - $6.15 Million	51,905 New	51,905 $3.46 Million

Others Institutions Holding HAE

# of Institutions

343

Shares Held

53.3M

Call Options Held

414K

Put Options Held

306K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.56B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account